Patients newly diagnosed with clinical type 2 diabetes mellitus but presenting with HbA1c within normal range: 19-Year mortality and clinical outcomes

Primary Care Diabetes

Volumn 7, Issue 1, 2013, Pages 33-38

  Veloso, A G ^a   Siersma, V ^a   Heldgaard, P E ^a   De Fine Olivarius, N ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

All cause mortality; Cardiovascular risk; Diagnosis; HbA1c; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DENMARK; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84875270577     PISSN: 17519918     EISSN: 18780210     Source Type: Journal    
DOI: 10.1016/j.pcd.2012.09.001     Document Type: Article

References (20)

1. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 2009 1327 1334
2. 1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation Diabetes Research and Clinical Practice 93 2011 299 309
3. E. Bonora, and J. Tuomilehto The pros and cons of diagnosing diabetes with A1C Diabetes Care 34 Suppl. 2 2011 S184 S190
4. D.M. Nathan, H. Turgeon, and S. Regan Relationship between glycated haemoglobin levels and mean glucose levels over time Diabetologia 50 2007 2239 2244
5. 1c The Danish Inter99 study Diabetic Medicine 27 2010 906 910
6. E. van't Riet, M. Alssema, and J.M. Rijkelijkhuizen Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study Diabetes Care 33 2010 61 66
7. N.F. Olivarius, H. Beck-Nielsen, and A.H. Andreasen Randomised controlled trial of structured personal care of type 2 diabetes mellitus British Medicine Journal 323 2001 970 975
8. J.D. Kalbfleisch, R.L. Prentice, The Statistical Analysis of Failure Time Data, New York, 2002.
9. D.L. Christensen, D.R. Witte, and L. Kaduka Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups Diabetes Care 33 2010 580 582
10. 1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark Diabetologia 54 2011 1318 1326
11. E. Selvin, S. Marinopoulos, and G. Berkenblit Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Annals of Internal Medicine 141 2004 421 431
12. T. Lauritzen, A. Sandbaek, A.H. Carlsen, and K. Borch-Johnsen All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark Primary Care Diabetes 6 2012 193 200
13. E. Selvin, M.W. Steffes, and H. Zhu Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults New England Journal of Medicine 362 2010 800 811
14. M.V. Skriver, K. Borch-Johnsen, T. Lauritzen, and A. Sandbaek HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION), Denmark Diabetologia 53 2010 2328 2333
15. F. Cavalot, A. Pagliarino, and M. Valle Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the san luigi gonzaga diabetes study Diabetes Care 34 2011 2237 2243
16. K. Eeg-Olofsson, J. Cederholm, and P.M. Nilsson New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR) Journal of Internal Medicine 268 2010 471 482
17. M. Hanefeld, S. Fischer, and U. Julius Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up Diabetologia 39 1996 1577 1583
18. 1c Journal of Clinical Epidemiology 57 2004 590 596
19. 1c level Diabetes Care 23 2000 1830 1834
20. N. Sattar Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities Diabetic Medicine 29 2012 5 13